E, F., M, H., K, T., J, I., Y, B., M, M., . . . K, Y. (2025). Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 182, 117749. https://doi.org/10.1016/j.biopha.2024.117749
Chicago Style (17th ed.) CitationE, Funayama, et al. "Oral Administration of Bifidobacterium Longum and Bifidobacterium Infantis Ameliorates Cefcapene Pivoxil-induced Attenuation of Anti-programmed Cell Death Protein-1 Antibody Action in Mice." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 182 (2025): 117749. https://doi.org/10.1016/j.biopha.2024.117749.
MLA (9th ed.) CitationE, Funayama, et al. "Oral Administration of Bifidobacterium Longum and Bifidobacterium Infantis Ameliorates Cefcapene Pivoxil-induced Attenuation of Anti-programmed Cell Death Protein-1 Antibody Action in Mice." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 182, 2025, p. 117749, https://doi.org/10.1016/j.biopha.2024.117749.